Theralife

Abbott Diabetes Care, located in Alameda, Calif., designs, develops and manufactures several glucose monitoring systems and test strips for use in both home and hospital settings. Among its brands are FreeStyle, FreeStyle Flash, Precision Xtra and Precision PCx. Abbott entered the blood glucose monitoring marketplace with the acquisition of MediSense in 1996. In 2004, the company acquired TheraSense, a leader in developing blood glucose self-monitoring devices that require very small blood samples to deliver rapid test results. ADC is a subsidiary of Abbott Laboratories, a global health care company devoted to the discovery of pharmaceuticals and medical products, including nutritionals, devices and diagnostics.

ARK Diagnostics is a leading provider of in vitro diagnostic immunoassays for therapeutic drug monitoring and urine drug testing, offering a wide range of assays for the qualitative and quantitative determination of various substances such as tramadol, voriconazole, EDDP, fentanyl, and methotrexate. Their next generation assays are known for their exceptional technical performance, liquid stability, and ready-to-use convenience, with applications available for clinical chemistry systems. With a focus on improving healthcare, ARK Diagnostics is committed to developing innovative solutions for clinical laboratory testing, including assays for epilepsy, cancer, antibiotics, antifungal, urine drug testing, antiretroviral, veterinary, and oral anticoagulants.Generated from the website